Status: retired, Primitive. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3500222018 | Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
3676223010 | Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Acebutolol and hydrochlorothiazide only product in oral dose form | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Acebutolol+diuretic | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Acebutolol | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Acebutolol- and hydrochlorothiazide-containing product | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Acebutolol - chemical | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Acebutolol | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Some | 1 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has BoSS | Hydrochlorothiazide | false | Inferred relationship | Some | 1 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Some | 1 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Some | 1 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Acebutolol | false | Inferred relationship | Some | 2 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has BoSS | Acebutolol | false | Inferred relationship | Some | 2 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 2 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Some | 2 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Acebutolol | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Is a | Acebutolol- and hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has precise active ingredient | Hydrochlorothiazide | false | Inferred relationship | Some | 1 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Has precise active ingredient | Acebutolol | false | Inferred relationship | Some | 2 | |
Acebutolol 200 mg and hydrochlorothiazide 12.5 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set